Trial intelligence / Profile preview

Intravenous ondansetron versus sub-hypnotic propofol for intrathecal opioid-induced pruritus after elective cesarean section

IRCT2017041527677N7Phase 3Completed

Sponsor
Urmia University of Medical Sciences (Vice Chancellor for Research)
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ondansetron and propofol in opioid-induced pruritus (OIP) and Nausea and Vomiting (2 arms), sponsored by Urmia University of Medical Sciences (Vice Chancellor for Research). Started Jul 2016; status: completed.

02

Drugs

ondansetronpropofol
03

Conditions

opioid-induced pruritus (OIP)Nausea and Vomiting

Beyond the preview

Go deeper on IRCT2017041527677N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017041527677N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call